NUR 622 (Adult_Gero Acute) MOD #7, Pneumonia, resp. viruses Questions with CORRECT
Answers (Grade A+)
Question 1:
strep pneumoniae, Hib, Moraxella, Legionella, Mycoplasma, mycobacterium TB
flu/RSV/adenovirus are more common in
Answer:
community acquired pneumonia (CAP)
Question 2:
pseudomonas, Staph. Aureus (MRSA/MSSA), Klebsiella, E.coli, Acinetobacter are more common is
Answer:
Hospital acquired pneumonia (HAP)
Question 3:
for patients with severe disease from pneumonia, or if you are treating MRSA/pseudomonas,
obtain both
Answer:
sputum and blood cultures
Question 4:
most common CAP organisms
Answer:
bacterial - strep pneumoniae virus - RSV/SARS-COV2
Question 5:
tx healthy patients with CAP (3 options) (no risk for MRSA/no ABX use is past 90 days)
Answer:
Amox 1gm PO TID for 5 days OR 2. Doxycycline 100mg PO BID for 5 days OR 3. Azithromycin 500mg
PO daily x 3 days (only recommended if resistance is low)
Question 6:
tx patients with comorbidities (COPD/DM/CKD, cancer) with CAP -previous ABX use within 90 days
, Answer:
Azithromycin or Doxycycline (same dosage) + Augmentin OR Levofloxacin, Moxifloxacin
monotherapy
Question 7:
two tools (on MD Calc) on whether to admit a patient for CAP
Answer:
Curb-65 PSI/PORT score
Question 8:
CURB-65 results
Answer:
1) Confusion 2) BUN>19 3) RR>30 4) BP<90/60 5) 65yo One or less indicates patient can be treated
outpatient, >1 =hospitalization, >3 = consider ICU
Question 9:
tx non-severe inpatient CAP
Answer:
IV beta lactam (ampicillin/sulbactam, Ceftriaxone, Ceftaroline) + a macrolide (Azithromycin/
Clarithromycin) OR -fluroquinolone monotherapy (cipro/levofloxacin/moxifloxacin) examples:
ceftriaxone 1gm daily + azithromycin 500mg daily OR ciprofloxacin 400mg IV
Question 10:
so again, for non-severe inpatient CAP, you will treat with
Answer:
an IV beta lactam + a macrolide OR fluroquinolone mono therapy
Question 11:
tx severe inpatient CAP
Answer:
Beta lactam + Macrolide OR Beta lactam + FQN
Question 12:
if:
Answers (Grade A+)
Question 1:
strep pneumoniae, Hib, Moraxella, Legionella, Mycoplasma, mycobacterium TB
flu/RSV/adenovirus are more common in
Answer:
community acquired pneumonia (CAP)
Question 2:
pseudomonas, Staph. Aureus (MRSA/MSSA), Klebsiella, E.coli, Acinetobacter are more common is
Answer:
Hospital acquired pneumonia (HAP)
Question 3:
for patients with severe disease from pneumonia, or if you are treating MRSA/pseudomonas,
obtain both
Answer:
sputum and blood cultures
Question 4:
most common CAP organisms
Answer:
bacterial - strep pneumoniae virus - RSV/SARS-COV2
Question 5:
tx healthy patients with CAP (3 options) (no risk for MRSA/no ABX use is past 90 days)
Answer:
Amox 1gm PO TID for 5 days OR 2. Doxycycline 100mg PO BID for 5 days OR 3. Azithromycin 500mg
PO daily x 3 days (only recommended if resistance is low)
Question 6:
tx patients with comorbidities (COPD/DM/CKD, cancer) with CAP -previous ABX use within 90 days
, Answer:
Azithromycin or Doxycycline (same dosage) + Augmentin OR Levofloxacin, Moxifloxacin
monotherapy
Question 7:
two tools (on MD Calc) on whether to admit a patient for CAP
Answer:
Curb-65 PSI/PORT score
Question 8:
CURB-65 results
Answer:
1) Confusion 2) BUN>19 3) RR>30 4) BP<90/60 5) 65yo One or less indicates patient can be treated
outpatient, >1 =hospitalization, >3 = consider ICU
Question 9:
tx non-severe inpatient CAP
Answer:
IV beta lactam (ampicillin/sulbactam, Ceftriaxone, Ceftaroline) + a macrolide (Azithromycin/
Clarithromycin) OR -fluroquinolone monotherapy (cipro/levofloxacin/moxifloxacin) examples:
ceftriaxone 1gm daily + azithromycin 500mg daily OR ciprofloxacin 400mg IV
Question 10:
so again, for non-severe inpatient CAP, you will treat with
Answer:
an IV beta lactam + a macrolide OR fluroquinolone mono therapy
Question 11:
tx severe inpatient CAP
Answer:
Beta lactam + Macrolide OR Beta lactam + FQN
Question 12:
if:
